Origent Data Sciences
Private Company
Funding information not available
Overview
Origent Data Sciences is a private, revenue-generating AI/ML platform company founded in 2015. It leverages predictive analytics and natural language processing to address two core challenges in healthcare: the high cost/risk of clinical trials and the delayed diagnosis of complex diseases like ALS. Its technology suite includes predictive models for trial optimization, AI-driven clinical decision support tools for early detection, and the MyJourney app, an AI companion that captures patient-reported data. Origent's solutions target biopharma sponsors, CROs, clinicians, and patients, creating a new category of narrative-derived health intelligence.
Technology Platform
AI/ML platform combining predictive analytics for clinical trial optimization (patient-level forecasting, virtual controls) with an AI health companion (MyJourney app) that uses NLP to transform unstructured patient narratives into structured, actionable health data and clinical decision support tools.
Opportunities
Risk Factors
Competitive Landscape
Origent competes with generalist clinical trial AI companies (e.g., Unlearn.AI, Saama) and broader digital health platforms, but differentiates through its deep, proven specialization in ALS and neurodegenerative diseases. It also faces competition from other patient-facing symptom tracker and PRO apps, though its direct integration with clinical research and diagnostic support is a key differentiator.